Papilloma Virus, Human, Type 6 L1, Late Protein, Recombinant (hPV)

Products_type

Recombinant Protein
Products_short_name

[Papilloma Virus, Type 6 L1, Late Protein]
Purity

Highly Purified90% by sequential chromatography.
Form

Supplied as a liquid in 200mM sodium citrate, 10mM magnesium chloride, 0.2% thioglycerol, 0.05% Tween 80, pH 7.5.
Storage_stability

Aliquot to avoid repeated freezing and thawing and store at -70 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquots are stable for 6 months.
Properties

Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
Source

Recombinants or rec. proteins
Group

recombinants

Gene target

Papilloma Virus Late Protein hPV
Short name

Papilloma Virus, , 6 L1, Late Protein, Recombinant (hPV)
Technique

Recombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. MyBioSource advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
Host

Yeast
Species

Human, Humans, Viruses
Alternative name

Papilloma Virus, H. sapiens, classification 6 L1, Late Protein, Rec. (cervical cancer virus)
Alternative technique

rec
Virus

papilloma

Name

Primary Cell Culture
Concept

Scope note: The initial culturing of cells derived directly from fresh TISSUES.
Tree numbers
- E01.370.225.500.223.500
- E05.200.500.265.500
- E05.242.223.500
- E05.481.500.249.500
Qualifiers

ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data